Sign in
4

Changes in Ownership

Bolt Biotherapeutics, Inc. Filed Acc 0001193125-25-321146

Options or other derivatives

  • President, CEO and CFO acquired 108,286 shares (grant or award)
  • President, CEO and CFO returned 108,286 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Quinn William P. · President, CEO and CFO

Table II: Derivative

16 lines
Date Transaction Shares Owned after D/I
2025-12-12 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +7,614 7,614 D
2025-12-12 Returned to the company : show line 2 in the form Employee Stock Option (Right to Buy) −7,614 0 D
2025-12-12 Grant or award : show line 3 in the form Employee Stock Option (Right to Buy) +3,927 3,927 D
2025-12-12 Returned to the company : show line 4 in the form Employee Stock Option (Right to Buy) −3,927 0 D
2025-12-12 Grant or award : show line 5 in the form Employee Stock Option (Right to Buy) +5,000 5,000 D
2025-12-12 Returned to the company : show line 6 in the form Employee Stock Option (Right to Buy) −5,000 0 D
2025-12-12 Grant or award : show line 7 in the form Employee Stock Option (Right to Buy) +10,499 10,499 D
2025-12-12 Returned to the company : show line 8 in the form Employee Stock Option (Right to Buy) −10,499 0 D
Loading xslF345X05/ownership.xml…